Breast imaging hindered during covid-19 pandemic, in Brazil
DOI:
https://doi.org/10.11606/s1518-8787.2021055003375Keywords:
Mammography, statistics & numerical data, Breast neoplasms, diagnosis, Coronavirus infections, State health care coverageAbstract
OBJECTIVE: To report the decrease in breast imaging after covid-19 pandemic, obtaining the number of mammograms performed in 2019 and 2020. Additionally, to investigate if there was an increase in the proportion of women undergoing mammography for diagnostic purposes, with palpable lesions. METHOD: This is a cross-sectional study, based on the number of mammograms performed by the Brazilian public health services, provided by DATASUS, an open access database. Mammograms from private institutions were not included. This study compares the number of mammograms performed in 2019 and 2020, in women aged 50–69 years, stratified by month, in each federal state, and the presence of palpable lumps (physician-reported). RESULTS: In total, 1,948,471 mammograms were performed in 2019 and 1,126,688 in 2020, for the population studied. These values represent a 42% decline. Monthly, a significant decreased is observed after April 2020. The results varied slightly according to federal state; yet the entire country was affected. Rondônia was the most affected state, with 67% decline. The proportion of women presenting palpable lumps increased from 7.06% on average in 2019 to 7.94% in 2020 (OR = 1.135, 95%CI 1.125–1.145, p = 0,001). DISCUSSION: The number of mammograms performed in 2020 declined considerably. Out of the women who presented for mammogram, the proportion of palpable lumps was significantly higher in 2020. Considering the detection rate of digital mammography, the loss of 800,000 exams means 4,000 undiagnosed breast cancer cases, by the end of 2020.
References
Zhou P, Yang XL, Wang XG, HU B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-3. https://doi.org/10.1038/s41586-020-2012-7
World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva: WHO; 2020 [cited 2020 Nov 26]. Available from: https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. Geneva: WHO; 2020 [cited 2020 Nov 26]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Geneva: WHO; 2021 [cited 2021 Jan 19]. Available from: https://covid19.who.int
São Paulo (Estado). Portal do Governo, Sala de Imprensa. Doria determina quarentena em todo o Estado de São Paulo. Releases. 21 mar 2020 [cited 2020 Nov 26]. Available from: https://www.saopaulo.sp.gov.br/sala-de-imprensa/release/doria-determina-quarentena-em-todo-o-estado-de-sao-paulo/
Agência Nacional de Saúde Suplementar. ANS orienta: consultas, exames e cirurgias que não sejam urgentes devem ser adiados. Brasília, DF: ANS; 17 mar 2020 [cited 2020 Nov 26]. Available from: http://www.ans.gov.br/aans/noticias-ans/consumidor/5426-ans-orienta-consultas-exames-e-cirurgias-que-nao-sejam-urgentes-devem-ser-adiados
Ministério da Saúde (BR), DATASUS. Informações em saúde: Mortalidade - Brasil. Brasília, DF; 2020 [cited 2020 Dec 29]. Available from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sim/cnv/obt10uf.def
Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2019.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al; CONCORD Working Group. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;17;391(10125):1023-75. https://doi.org/10.1016/S0140-6736(17)33326-3
Migowski A, Silva GA, Dias MBK, Diz MDPE, Sant'Ana DR, Nadanovsky P. Guidelines for early detection of breast cancer in Brazil. II - New national recommendations, main evidence, and controversies. Cad Saude Publica. 2018;34(6):e00074817. https://doi.org/10.1590/0102-311X00074817
Urban LABD, Chala LF, Bauab SP, Schaefer MB, Santos RP, Maranhão NMA, et al. Recomendações do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, da Sociedade Brasileira de Mastologia e da Federação Brasileira das Associações de Ginecologia e Obstetrícia para o rastreamento do câncer de mama. Radiol Bras. 2017;50(4):244-9. https://doi.org/10.1590/0100-3984.2017-0069
Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde 2013: percepção do estado de saúde, estilos de vida e doenças crônicas - Brasil, grandes regiões e unidades de federação. Rio de Janeiro: IBGE; 2014.
American Cancer Society. Breast cancer facts & figures 2019-2020. Atlanta, GA: American Cancer Society; 2019.
Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, et al; Breast Cancer Surveillance Consortium. Breast tumor prognostic characteristics and biennial vs annual mammography, age, and menopausal status. JAMA Oncol. 2015;1(8):1069-77. https://doi.org/10.1001/jamaoncol.2015.3084
Gøtzsche PC, Jørgensen KJ; Cochrane Breast Cancer Group. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;2013(6):CD001877. https://doi.org/10.1002/14651858.CD001877.pub5
Werutsky G, Nunes P, Barrios C. Locally advanced breast cancer in Brazil: current status and future perspectives. Ecancermedicalscience. 2019;13:895. https://doi.org/10.3332/ecancer.2019.895
Simon SD, Bines J, Werutsky G, Nunes JS, Pacheco FC, Segalla JG, et al. Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study. Breast. 2019;44:113-9. https://doi.org/10.1016/j.breast.2019.01.008
Gonçalves R, Soares Jr JM, Baracat EC, Filassi JR. Ethical issues surrounding breast cancer screening in Brazil. Clinics (Sao Paulo). 2019;74:e1573. https://doi.org/10.6061/clinics/2019/e1573
Caleffi M, Crivelatti I, Burchardt NA, Ribeiro RA, Acevedo Y, Job LG, et al. Breast cancer survival in Brazil: how much health care access impact on cancer outcomes? Breast. 2020;54:155-9. https://doi.org/10.1016/j.breast.2020.10.001
Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DSM, Kerlikowske K, et al. National performance benchmarks for modern screening digital mammography: update from the Breast Cancer Surveillance Consortium. Radiology. 2017;283(1):49-58. https://doi.org/10.1148/radiol.2016161174
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Jordana de Faria Bessa
This work is licensed under a Creative Commons Attribution 4.0 International License.
